Hot to trot with Zilretta, Flexion rolls $100M-plus stock offering to fund the launch
admin 11th October 2017 Uncategorised 0Less than a week after winning FDA approval for its knee arthritis injection Zilretta—which analysts peg as a blockbuster standard-of-care med—Flexion is floating a $100 million-plus stock offering to fund the drug’s rollout.
More: Hot to trot with Zilretta, Flexion rolls 0M-plus stock offering to fund the launch
Source: fierce